rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2
|
pubmed:dateCreated |
2004-2-4
|
pubmed:abstractText |
This study was designed to assess the feasibility and safety of enoxaparin in combination with glycoprotein (GP) IIb/IIIa inhibitors during percutaneous coronary intervention (PCI) as part of an early invasive strategy in patients presenting with acute coronary syndromes (ACS).
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
1042-3931
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
16
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
46-51
|
pubmed:dateRevised |
2010-11-18
|
pubmed:meshHeading |
pubmed-meshheading:14760188-Acute Disease,
pubmed-meshheading:14760188-Angioplasty, Balloon, Coronary,
pubmed-meshheading:14760188-Anticoagulants,
pubmed-meshheading:14760188-Coronary Disease,
pubmed-meshheading:14760188-Drug Therapy, Combination,
pubmed-meshheading:14760188-Enoxaparin,
pubmed-meshheading:14760188-Factor Xa,
pubmed-meshheading:14760188-Female,
pubmed-meshheading:14760188-Humans,
pubmed-meshheading:14760188-Male,
pubmed-meshheading:14760188-Middle Aged,
pubmed-meshheading:14760188-Ohio,
pubmed-meshheading:14760188-Pilot Projects,
pubmed-meshheading:14760188-Platelet Aggregation Inhibitors,
pubmed-meshheading:14760188-Platelet Glycoprotein GPIIb-IIIa Complex,
pubmed-meshheading:14760188-Prospective Studies,
pubmed-meshheading:14760188-Syndrome,
pubmed-meshheading:14760188-Time Factors,
pubmed-meshheading:14760188-Treatment Outcome
|
pubmed:year |
2004
|
pubmed:articleTitle |
The combination of enoxaparin, glycoprotein IIb/IIIa inhibitors and an early invasive approach among acute coronary syndrome patients.
|
pubmed:affiliation |
Cleveland Clinic Foundation, Department of Cardiovascular Medicine, Desk F25, 9500 Euclid Avenue, Cleveland, OH 44195, USA. bhattd@ccf.org
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Controlled Clinical Trial,
Research Support, Non-U.S. Gov't
|